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Noma (cancrum oris), a neglected tropical disease, rapidly disintegrates the hard and soft
tissue of the face and leads to severe disfiguration and high mortality. The disease is poorly
understood. We aimed to estimate risk factors for diagnosed noma to better guide existing
prevention and treatment strategies using a case-control study design.
Methods
Cases were patients admitted between May 2015 and June 2016, who were under 15 years
of age at reported onset of the disease. Controls were individuals matched to cases by vil-
lage, age and sex. Caretakers answered the questionnaires. Risk factors for diagnosed
noma were estimated by calculating unadjusted and adjusted odds ratios (ORs) and respec-
tive 95% confidence intervals (CI) using conditional logistic regression.
Findings
We included 74 cases and 222 controls (both median age 5 (IQR 3, 15)). Five cases (6.5%)
and 36 (16.2%) controls had a vaccination card (p = 0.03). Vaccination coverage for polio
and measles was below 7% in both groups. The two main reported water sources were a
bore hole in the village (cases n = 27, 35.1%; controls n = 63, 28.4%; p = 0.08), and a well in
the compound (cases n = 24, 31.2%; controls n = 102, 45.9%; p = 0.08). The adjusted analy-
sis identified potential risk and protective factors for diagnosed noma which need further
exploration. These include the potential risk factor of the child being fed pap every day (OR
9.8; CI 1.5, 62.7); and potential protective factors including the mother being the primary
caretaker (OR 0.08; CI 0.01, 0.5); the caretaker being married (OR 0.006; CI 0.0006, 0.5)
and colostrum being given to the baby (OR 0.4; CI 0.09, 2.09).
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Interpretation
This study suggests that social conditions and infant feeding practices are potentially asso-
ciated with being a diagnosed noma case in northwest Nigeria; these findings warrant fur-
ther investigation into these factors.
Author summary
Noma or cancrum oris is an orofacial gangrene that rapidly disintegrates the hard and soft
tissue of the face. Little is known about noma as most cases live in underserved, difficult to
reach locations. There is a dearth of literature on the risk factors for the development of
noma. Me´decins Sans Frontières (MSF) in collaboration with the Nigerian Ministry of
Health runs projects at the Noma Children’s Hospital in Sokoto. A case control study was
conducted in northwest Nigeria to explore exposures associated with diagnosed noma
using unadjusted and adjusted conditional logistic regression models. Potential risk and
protective factors for diagnosed noma were identified and these findings need further
exploration. The study identified that feeding pap to the child every day was a potential
risk factor for diagnosed noma (possibly a proxy for poor variety in the diet). The follow-
ing potential protective factors for diagnosed noma were identified: the mother being the
primary caretaker, the caretaker being married, and colostrum being given to the baby.
Noma is a neglected disease, and current risk factors suggest that intervention efforts
could be more effective by focussing on access to health care, the benefits of breastfeeding
and a varied diet. However, more research is needed in order to better understand the
pathogenesis of this disease in order to improve prevention, early detection and
treatment.
Introduction
Noma or cancrum oris, is a poorly understood, rapidly progressing gangrenous infection of
the oral cavity, associated with a high mortality rate [1]. It mostly affects children under the
age of five years [2]. It is estimated that up to 90% of noma cases die [3], and those who survive
have severe facial disfigurements [2]. These can result in multiple physical impairments such
as difficulty speaking, swallowing, eating, seeing and breathing which can lead to stigmatiza-
tion in their communities [4]. Noma is thought to be most prevalent along the noma belt
which stretches from Senegal to Ethiopia [4], however noma cases have recently been reported
in the United Kingdom [5], United States [6], Afghanistan [7], South Korea [8] and Laos [9].
A northwest Nigerian based study concluded that the incidence of noma is estimated to be 6.4
per 1000 children [10], and the World Health Organization (WHO) estimates that 140 000
children contract noma each year globally [2].
Little is understood about noma as most cases live in underserved, difficult to reach loca-
tions, many cases go undiagnosed and the mortality rate is so high. Previous observational
studies have suggested that risk factors for development of noma include malnutrition, low
birthweight, absence of breastfeeding, poor oral hygiene, co-morbidities, proximity of live-
stock to area of residence, large family size, access to unsafe drinking water and living in a vil-
lage with a high prevalence of acute necrotising gingivitis [4,11–13]. Recently, an increased
incidence of noma has been reported in higher resource settings in patients with immunosup-
pressive diseases such as human immunodeficiency virus (HIV) [5,6,8,14,15].
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Since 2015, Me´decins Sans Frontières (MSF) has collaborated with the Nigerian Ministry of
Health (MoH) to treat noma patients identified across the northwest of Nigeria, in Sokoto.
The programme provides nutritional, psychosocial (for the patient and their families) and
medical care to prepare noma patients for the required surgical interventions at the Noma
Children’s Hospital. These are conducted by MoH and MSF surgical teams on a routine basis;
since August 2015, the programme has treated 227 noma patients. We conducted a case-con-
trol study to identify risk factors for diagnosed noma in terms of demographic characteristics,
medical history, socio-economic-behavioural aspects and access to health care in order to bet-
ter guide existing prevention and treatment strategies for this neglected disease.
Methods
Study location
The study was conducted in Sokoto and Kebbi states, which are located in northwest Nigeria.
Study population
Cases were defined as patients with diagnosed noma admitted to the Noma Children’s Hospi-
tal between May 2015 and June 2016 who were under 15 years of age at self-reported onset of
the disease. Controls were individuals matched to cases by village of residence, current age
(+/- 2 years) and sex.
Sample size
Our aim was to include all cases enrolled at the Noma Children’s Hospital in the year before
data collection, and we calculated that with a sample size of 67 cases and 200 controls (three
controls per case), we would be able to estimate an odds ratio (OR) of 2.5 for suspected risk
factors with a power of 80% and 60% of controls being exposed to that risk factor. Controls
were selected from houses neighbouring those in which the cases and their families live.
Data collection
Seventy-eight percent of cases and controls were younger than 18 years of age, their parents or
caretakers were asked to participate in the interviews using a structured questionnaire. The
questionnaire covered the sociodemographic characteristics of the cases and controls (age,
gender, education, employment, total household members), their current living conditions
(water source, proximity to livestock, material of houses) and their vaccination history (read
on vaccination card if available). Additionally, parents and/or caretakers were asked to
respond to questions pertaining to the duration of breastfeeding after the cases and controls
were born and other nutrition-related practices during the neonatal period and current prac-
tices. The health status, access to health care and healthcare seeking behaviour for the case or
control in the previous 12 months were also assessed. Finally, all cases and controls aged less
than five years at the time of interview had a mid-upper arm circumference (MUAC) measure-
ment taken at the time of the interview.
The questionnaire was formatted in Kobo Collect (http://www.kobotoolbox.org/) and
uploaded to tablets for mobile data collection purposes. Completed questionnaires were
uploaded daily to a secure MSF server through an internet connection. The study coordinator
verified all completed questionnaires on a daily basis for data consistency and quality.
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Data analysis
We calculated the frequencies and respective proportions for all categorical variables and used
chi-square tests for comparison of these variables between cases and controls. For continuous
variables, we calculated means with standard deviation or medians and interquartile ranges
(depending if approximately Normally distributed) for cases and controls separately, and used
t-tests to compare Normally distributed variables, and Kruskal Wallis tests for non-Normally
distributed variables.
Food variables for current feeding practices were categorised as animal products (meat,
milk, egg), grains (fura, mashed rice, millet, corn, bread) and vegetables (sweet potato, beans,
bean cake, moringa leaf with ground nut cake, cassava). Respondents could answer with ‘Yes’,
‘No’ and ‘Don’t know’. We grouped all responses for ‘No’ and ‘Don’t know’ into a single cate-
gory. To investigate the impact of this grouping, we conducted a sensitivity analysis for each of
these variables. As the results showed that the direction of association remained the same, we
retained this grouping as the reference category.
We estimated risk factors for being a diagnosed noma patient by comparing odds of expo-
sure in cases and controls using unadjusted and adjusted conditional logistic regression to cal-
culate Odds Ratios (ORs) and their respective 95% confidence intervals (CI) and p-values. The
adjusted conditional logistic regression model was constructed using all risk factors that had a
p-value of<0.2 in the unadjusted analysis and sufficient outcomes in each category. Variables
were eliminated from the adjusted model using a manual backwards stepwise approach [16],
and adjusted models were compared using the likelihood ratio test, any variable with a p-value
under 0.2 was kept in the model. All data analyses were conducted with Stata 14 (StataCorp,
College Station, TX, USA).
Ethics
The MSF Ethical Review Board approved the study protocol (study 1710), as did the Usmanu
Danfodiyo University Teaching Hospital (UDUTH) Health Research and Ethics Committee
in Nigeria (UDUTH/HREC/2017/No.595) and the Ministry of Health in both Sokoto
(SKHREC/032/017) and Kebbi (MOH/SUB/4027/Vol.I/14) states. All interviewees were over
the age of 18 and written informed consent was provided by each participant (for participants
who were illiterate, the consent form was read aloud to them and a thumb print was then
requested). All participants were assured that there was limited risk of harm from participation
in this study, and that they were free to withdraw at any point.
Results
General findings
Out of the 112 noma patients who had sought care in the programme between May 2015 and
June 2016, we identified 87 who lived in Kebbi and Sokoto states and were eligible for inclu-
sion in the study. Of these, 10 could not be located, and we managed to interview 77 cases
(88.5%). We were unable to reach the village of three identified cases for logistical reasons.
Thus, the final analysis included 74 noma cases and 222 controls. Six of the cases had passed
away in the time between discharge and the interview; the interviews were still conducted with
their caretakers. At the time of first admission to the hospital, 17 of these cases had acute
noma, 57 had inactive noma, two had trismus and one had no diagnosis noted at time of
admission to the hospital. Twenty one cases were hospitalized at the time of interview and the
remaining 56 were interviewed in their home villages.
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As expected, there were no significant differences in matching variables (sex and age of
child) between cases and controls. The control group differed from the case group in that care-
takers were younger, their family sizes were smaller (and houses in the compound fewer) and
most of their houses were made of mud (which might be a proxy for higher socio-economic
status) (Table 1). Also, the respondents for the control group were more frequently the mother
of the child (Table 1). The self-reported median age of onset of noma amongst cases was 2.0
(IQR 2.0, 3.0).
Cases between 6 months and 5 years old had lower mean MUAC measurements (mean
134; SD 20) than controls (mean 142; SD 11; p = 0.002. Six percent of cases (n = 5) had a vacci-
nation card available at the time of interview, compared with 16% (n = 36; p = 0.03) of con-
trols. The vaccination status (based on the vaccination card was) for polio (cases n = 3, 3.9%;
controls n = 13, 5.9%; p = 0.07) and measles (cases n = 2, 2.6%; controls n = 15, 6.8%; p = 0.1)
was very low for both cases and controls. Parents and caretakers reported that most cases
(n = 63, 81.8%) and controls (n = 158, 71.2%; p = 0.22) had been breastfed between one to two
years after birth. With respect to the main source of drinking water, parents reported that the
two main water sources were a bore hole in the village (cases n = 27, 35.1%; controls n = 63,
28.4%; p = 0.08) and a well in the family compound (cases n = 24, 31.2%; controls n = 102,
46.0%; p = 0.08). In terms of animal ownership, the proportion of case and control families
reporting owning donkeys, dogs, sheep, goats and chickens were similar. Case families, how-
ever, were less likely to have cows in their compound compared with controls (cases n = 36,
46.8%; controls n = 128, 57.7%; p = 0.09).
Risk factor analysis
The unadjusted analysis suggested that the likelihood of being a diagnosed noma case
increased when the household was large (>10 people), the child was heavy at birth (self-
Table 1. Sociodemographic characteristics of cases and controls (p-values from chi-squared, t-test or kwallis).
Controls (N = 222) Cases (N = 77) P-value
Child age at time of interview, Median (IQR) 5.0 (3.0, 15.0) 5.0 (3.0, 15.0) 0.94
Caretaker sex (female) 113 (50.9%) 37 (48.1%) 0.67
Caretaker age 18–25 147 (68.7%) 37 (48.7%) 0.002
35–90 67 (31.3%) 39 (51.3%)
Missing 8 1
Child first born 33 (14.9%) 13 (16.9%) 0.67
Family size, Mean (SD) 11.5 (8.8) 15.8 (13.8) 0.0016
Number of wives, Mean (SD) 2.0 (7.6) 1.6 (0.7) 0.64
Main caretaker Mother 132 (59.5%) 25 (32.5%) <0.001
Other 36 (16.2%) 28 (36.4%)
NA 54 (24.3%) 24 (31.2%)
Caretaker employed No 76 (45.2%) 33 (51.6%) 0.39
Yes 92 (54.8%) 31 (48.4%)
Missing/ NA 54 13
Caretaker education None 66 (29.7%) 28 (43.8%) 0.34
Educated 102 (46.0%) 36 (56.3%)
Number of houses in compound, Mean (SD) 3.5 (2.8) 4.5 (3.5) 0.008
Main materials of house walls Wood, mud, bamboo 175 (78.8%) 41 (53.3%) <0.001
Stone, brick, cement 45 (20.3%) 12 (15.6%)
Other 2 (0.9%) 24 (31.2%)
https://doi.org/10.1371/journal.pntd.0006631.t001
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reported weight), breastfeeding occurred for >1 year, first solid food was given after the age of
12 months, the child ate pap (type of porridge staple made from maize, sorghum, or millet),
and grains each day. Protective factors against acquiring noma included: the mother being the
primary caretaker, the caretaker being married, having a well in the compound, colostrum
being given to the child, child first given water over the age of 7 months, all children in the
household being alive and the child having taken medication (traditional or biomedicine) in
the year preceding the interview (Table 2).
Due to collinearity, the following variables were not included in the adjusted analysis: the
food group variable “Grains” (fura, mashed rice, millet, corn, bread), material the walls of the
house was made out of, wealth score, measles, polio, one or more vaccination being reported
on a vaccination card. In the adjusted analysis, eating pap every day remained strongly associ-
ated with being a risk factor for diagnosed noma (OR 9.8; CI 1.5, 62.7; p = 0.02) as did a later
age of first solid food (>12 months) (OR 5.07; CI 0.9, 26.08; p = 0.07). Variables that were pro-
tective against being a case included the mother being the primary caretaker (OR 0.08; CI 0.01,
0.5; p = 0.007), the caretaker being married (OR 0.006; CI 0.0006, 0.5; p =<0.001) and colos-
trum being given to the baby (OR 0.4; CI 0.09, 2.09; p = 0.07) (Table 2).
Discussion
This study has highlighted potential risk and protective factors associated with being a diag-
nosed noma case in northwest Nigeria, including caretaker demographics and infant feeding
practices. This identification aims to shed light on potential useful areas for further investiga-
tion. Similar risk factors have been suggested including the absence of breastfeeding [12], die-
tary habits [17], unsafe drinking water, limited access to high quality health care, high infant
mortality [4], and food security [11]. A 2017 review noted that measles vaccination was a
protective factor for noma [11], but we were unable to corroborate this as the estimated vacci-
nation coverage in both cases and controls was too low for a relevant comparison to be con-
ducted. Our adjusted analysis did not identify an association between noma and household
size or water source as reported elsewhere [9,12,18], however, the unadjusted analysis sug-
gested a possible association between these exposures and diagnosed noma and therefore war-
rants further investigation. We were also unable to confirm other reported risk factors for
noma including high numbers of previous pregnancies in the mother, [12] pre-existing illness,
malnutrition [17], poor oral hygiene practices [1,2,4,9–11,18–23], proximity of livestock to the
area of residence and low birthweight [2,4,7,12,18,20,23,24], these require further exploration.
One novel observation of the study was some weak evidence for the possible protective
nature of colostrum. There are inherent health benefits associated with colostrum as it is rich
in antibodies that confer passive immunity and growth factors which have been shown in
recent studies to assist in the treatment of autoimmune disorders and gastrointestinal condi-
tions [25]. Recent case reports have highlighted the global problem of noma and in some cases
a relation to concomitant infections including HIV-positive patients in London [5] and in the
United States [6], and a Korean child with Crohn’s disease [8]. These reports offer insight into
the disease and strongly suggest that immunosuppression plays a role in the causal pathway of
noma development which supports the finding of the protective nature of colostrum. How-
ever, it should be noted that these are clinical case reports and not analytical epidemiological
studies. It is also possible that mothers who give their children colostrum are also more likely
to follow other health messaging. Both aspects would have a favourable impact on the overall
health status of an infant and therefore render the child to be at a lower risk of noma develop-
ment. Our findings on this point were not definitive but this could be a useful point for future
research.
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Table 2. Unadjusted and adjusted risk factors for being a noma case from conditional logistic regression, Sokoto and Kebbi States, Nigeria 2017.
Controls (N = 222) Cases (N = 77) Unadjusted Adjusted
n (%) n (%) OR 95% CI P-Value OR 95% CI P-Value
Primary Caretaker is mother 132 (60%) 25 (32%) 0.2 0.1, 0.5 <0.001 0.08 0.01, 0.5 0.007
Caretaker married 158 (71%) 14 (18%) 0.03 0.01, 0.09 <0.001 0.006 0.0006, 0.5 <0.001
Child first born 33 (15%) 13 (17%) 1.2 0.6, 2.5 0.6
Caretaker Educated 102 (46%) 36 (47%) 1 0.6, 1.8 1
Caretaker Employed 92 (41%) 31 (40%) 0.9 0.5, 1.7 0.9
Total household members 1–9 113 (51%) 29 (38%) Reference
10 or above 109 (49%) 48 (62%) 1.8 1.006, 3.09 0.05 2.06 0.8, 5.3 0.1
COMPOUND LIFE
Water Source Other 120 (54%) 53 (69%) Reference
Well in compound 102 (46%) 24 (31%) 0.5 0.2, 0.9 0.04
Water treated 73 (33%) 24 (31%) 0.9 0.5, 1.6 0.8
Electricity Yes 77 (35%) 25 (32%) 0.5 0.2, 1.4 0.2 0.2 0.04, 1.5 0.1
Livestock in compound 1–3 100 (45%) 40 (52%) Reference
4 or more animal species 122 (55%) 37 (48%) 0.8 0.4, 1.4 0.4
NUTRITION
Colostrum No 19 (9%) 19 (25%) Reference Reference
Yes 149 (67%) 44 (57%) 0.3 0.2, 0.7 0.002 0.4 0.09, 2.09 0.07
Don’t know 54 (24%) 14 (18%) 0.05 0.005, 0.4 0.001 3.3e-06, 0.5
Breastfed length 7–12 mnth, other 64 (29%) 14 (18%) Reference
>1 year and <2 years 158 (71%) 63 (82%) 16.9 2.1, 134.5 0.008
Age child first given water 0–6 126 (57%) 53 (69%) Reference
7 or above mnths 26 (12%) 6 (8%) 0.4 0.2, 1.2 0.03
Don’t know 70 (32%) 18 (23%) 0.2 0.07, 0.8
Age first given solid food 0–11 112 (51%) 44 (57%) Reference Reference
12 mnths or after 38 (17%) 16 (21%) 1.2 0.6, 2.3 0.03 5.07 0.9, 26.08 0.07
Don’t know 72 (33%) 17 (22%) 0.2 0.05, 0.7 0.2 0.01, 2.9
Pap every day (Y) 124 (56%) 55 (71%) 3.5 1.5, 8.2 0.004 9.8 1.5, 62.7 0.02
Food eaten at least once a day (Y) (ref = no/ don’t know)
Animal products 28 (13%) 10 (13%) 0.9 0.4, 2.1 0.9
Grains 165 (74%) 62 (81%) 5.9 1.2, 29.7 0.03
Vegetable 57 (26%) 21 (27%) 1 0.5, 1.9 1
Drinks 94 (42%) 36 (47%) 1.2 0.7, 2.2 0.6
Child, family eat same meals (Y) 165 (74%) 61 (79%) 3.4 0.8, 13.6 0.09
HEALTH
Births in total 0–5 99 (46%) 30 (39%) Reference
6 or more 69 (31%) 34 (44%) 1.4 0.8, 2.6 0.5
Don’t know 54 (24%) 13 (17%) 5.80E-08 0, -
Births Alive Some Died 64 (29%) 43 (56%) Reference
All still alive 103 (46%) 20 (26%) 0.4 0.2, 0.6 0.003
Don’t know 55 (25%) 14 (18%) 3.90E-08 0, -
Birthweight Light 27 (12%) 9 (12%) Reference
Heavy 78 (35%) 39 (51%) 1.6 0.7, 3.7 0.03
Don’t know 117 (53%) 29 (38%) 0.7 0.3, 1.7
Meds in previous year(Y) 127 (57%) 32 (42%) 0.4 0.2, 0.7 0.006 0.3 0.07, 1.6 0.2
https://doi.org/10.1371/journal.pntd.0006631.t002
Risk factors for diagnosed noma in northwest Nigeria: A case-control study, 2017
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006631 August 23, 2018 7 / 11
The finding in the unadjusted analysis that having taken medication in the year prior to the
study was a protective factor could indicate that having access to health care plays a role in
noma development. This could be due to health care proximity or possibly due to improved
socio economic status which would allow the families to pay for transport to get to health care
and/or healthcare provision. Those who develop noma would possibly have fewer possibilities
to seek care for other diseases or the beginning stages of noma, and as such are at higher risk
of developing the disease.
The finding that eating pap every day is a risk factor for diagnosed noma development,
could be due to the fact that pap is the food usually used for weaning in Nigeria, it has a low
nutrient density and has been reported to be at risk of unhygienic handling [26]. Two microbi-
ological analyses of foods commonly used in weaning (including pap) in Nigeria, showed bac-
terial contamination at higher levels than international guidelines recommend [27,28]. All of
these factors mean that during the weaning period, the use of pap can predispose infants to
infections and subsequently high mortality rates [26]. Possible solutions to reduce this expo-
sure, would be to strengthen education about hygienic food preparation [27], the benefits of
alternate practices such as fermentation which enhances nutritive value of the food [26] or
encouraging variety in the diet. Improving feeding during the weaning time is crucial to
decrease child malnutrition, mortality rates and to enhance development [28].
The findings showed that in both the case and control groups there was a high proportion
of child morbidity and that families where the majority of infants born to the same mother sur-
vived, were less likely to have a noma case. This finding might strengthen the role that socio-
demographic characteristics of families and households play in the disease dynamics of diag-
nosed noma. If more children die in households where noma cases are detected, it could indi-
cate that children in these households are also more exposed to unsafe water, poorer standards
of living and reduced access to care, as all of these exposures are known to be associated with
higher infant mortality [29–34].
The proportion of vaccination coverage in the study population is below the standards
recommended by the Nigerian Ministry of Health [35] and WHO [36]. There is evidence that
the occurrence of vaccine preventable diseases and malnutrition precede the onset of noma
[4,6,9,18–20]. The low coverage of vaccination not only increases the risk of morbidity and
mortality from vaccine preventable diseases, but is a contributing factor in immunosuppres-
sion which is thought to play a key role in the sequence of events for noma development.
Our study is unique because available evidence around noma manifestation and risk factors
for the development of the disease is based on a handful of primary studies [13,12,37], case
reports [5,7–9] and reviews [2,4,19]. These studies were methodologically different from ours
which could offer reasons for the differing findings. A case control study conducted in Niger
came closest to the current study design, although this study had an intake period of 6 years
and the controls were not matched on sex [12]. Our results also differ from those of a further
Niger-based study [13], which included four villages in the study population and focused on
the link between noma and acute necrotising gingivitis. In comparison, our study was con-
ducted over a relatively short time period and was retrospective in nature. Furthermore, our
cases and controls were matched on sex in addition to village of residence and age, which
might have eliminated some bias that could have been present in the previously mentioned
studies. Finally, our study included diagnosed noma cases who were resident across 80 villages
in two states of northwest Nigeria, so they represent a much wider geographical area than the
previous studies, which might have contributed to the differences in risk factors identified
[13].
We attempted to interview all patients cared for at the hospital in the year before data col-
lection, however this was not possible due to several constraints. Even though we managed to
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exceed our minimum sample size, we identified strong associations between only a minority
of the explored risk factors and diagnosed noma. It is likely that the risks associated with
individual exposures for noma are weaker than we assumed in the original sample size
calculation.
A further limitation is that our risk factor analysis only represents those cases who sought
care at the Noma Children’s Hospital in Sokoto. Due to the reported 90% mortality rate [3]
and rapid progression of noma, this likely means that the results of the current study are only
applicable to the subset of noma cases who experienced the least severe complications from the
disease.
Finally, we included all cases who were under the age of 15 at the time of self-reported dis-
ease onset. Therefore some cases (and thus controls) were under 15 at the age of onset but
were currently > = 18 (13 cases) therefore leading us to interview them personally and not
their caretaker. This might have introduced some bias into the study as certain questions
around infant feeding practices etc. would only have been possible to be answered by their
caretakers, thus leading to missing information on these questions. We tried to mitigate this
by conducting sensitivity analyses for these variables which resulted in similar findings.
Conclusions and recommendations
In conclusion, our case control study suggests that infant and current feeding behaviours as
well as caretaker demographics may affect the risk of developing noma. Malnutrition and low
vaccination coverage, high morbidity of infectious diseases along with low access to health
care are all likely contributing factors.
We recommend that further research is implemented to determine the true burden of
noma, and that prospective studies are implemented to better understand the sequence of
events contributing to the development of noma. Only with these sets of indicators will it be
possible to better formulate and target prevention programmes.
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